Consensus recommendation for meningococcal disease prevention in children and adolescents in the Middle East region

详细信息	查看全文 | 推荐本文 |

• 作者：Atef Shibl^a ; ^{amshibl@ksu.edu.sa} ; ^{amshibl1@yahoo.com} ; Haysam Tufenkeji^b ; Mohamed Khalil^c ; Ziad Memish^c ; The Meningococcal Leadership Forum (&ldquo ; MLF&rdquo ; ) Expert Group¹
• 关键词：Conjugate ; Consensus recommendation ; Invasive meningococcal disease ; Middle East countries ; Vaccine
• 刊名：Journal of Epidemiology and Global Health
• 出版年：2012
• 期刊代码：pca220_22106006
• 类别：med
• 出版时间：March, 2012
• 卷：2
• 期：1
• 页码：23-30
• 文件大小：204 K

摘要

Facing the availability of the new generation of quadrivalent meningococcal conjugate vaccines (Menveo庐, Menactra庐 and others pending for license) and their recent implementation in Saudi Arabia, experts from 11 countries of the Middle East region met at a 鈥淢eningococcal Leadership Forum鈥?(MLF), which took place in May 2010 in Dubai. The participants of the conference discussed the importance of introducing the concept of conjugate vaccines - especially for children and adolescents - and elaborated a consensus recommendation to support healthcare professionals and decision makers with their expertise. In experts鈥?opinion, conjugate vaccines are the best choice for the prevention of meningococcal disease caused by serogroups A, C, W-135 and Y. As quadrivalent meningococcal conjugate vaccines are registered and available in the Middle East region, they should replace plain polysaccharide vaccines and be integrated in pediatric and adolescent vaccination schedules, including infant vaccination concomitantly with basic EPI vaccines when licensed.